vindesine has been researched along with Congenital Thrombotic Thrombocytopenic Purpura in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brunot, A; Issler, M; Ojeda-Uribe, M | 1 |
1 other study(ies) available for vindesine and Congenital Thrombotic Thrombocytopenic Purpura
Article | Year |
---|---|
[Successful treatment of idiopathic acquired refractory thrombotic thrombocytopenic purpura with an association of rituximab-vindesine. Report of one case].
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Platelet Transfusion; Purpura, Thrombocytopenic, Idiopathic; Purpura, Thrombotic Thrombocytopenic; Recurrence; Rituximab; Treatment Outcome; Vindesine; von Willebrand Factor | 2005 |